News

A new study exploits the characteristic epigenetic signatures of childhood tumors to detect, classify and monitor the disease.

A new study used an ultrasensitive, single-molecule array (Simoa) assay to detect extremely low levels of molecules in the blood and measured how these levels change over the days and weeks following vaccination.

In a new study that appears in Nature Communications, scientists from Scripps Research investigated how the immune system’s previous exposure to cold-causing coronaviruses impact immune response to COVID-19. In doing so, they discovered one cross-reactive coronavirus antibody that’s triggered during a COVID-19 infection.

Researchers have developed a plasmofluidic chip that can perform PCR in about 8 minutes, which could speed diagnosis during current and future pandemics.

A new study from Washington University School of Medicine in St. Louis suggests that low testosterone levels in the blood are linked to more severe COVID-19 disease.

Researchers have designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours. The method, called SARSeq, could be adapted to many more pathogens.

To improve the development of new saliva-based diagnostic tests and personalized medicine, the National Institute of Dental and Craniofacial Research has supported the development of the Human Salivary Proteome Wiki, the first public platform that catalogs and curates data on each of the thousands of proteins within our saliva.

Researchers at Lund University in Sweden have developed an algorithm that combines data from a simple blood test and brief memory tests, to predict with great accuracy who will develop Alzheimer's disease in the future.

Researchers have validated a faster, cheaper COVID-19 test that could kickstart the expansion of more widespread rapid testing.

A new study suggests that urine IL-1α, IL-1ra and IL-8 could be useful indicators of bladder cancer.